In the BioHarmony Drug Report Database

"Preview" Icon

Imlifidase

Idefirix (imlifidase) is an enzyme pharmaceutical. Imlifidase was first approved as Idefirix on 2020-08-25. It has been approved in Europe to treat immunologic desensitization and kidney transplantation.

 

Trade Name

 

Idefirix
 

Common Name

 

imlifidase
 

ChEMBL ID

 

CHEMBL4297981
 

Indication

 

immunologic desensitization, kidney transplantation
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Imlifidase structure rendering